Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Search Icon
Search Icon
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Maternal & Public Health Ave Maria Law Review

Analyzing the Impact of State Level Contraception Mandates on Public Health Outcomes

Abstract

The recent mandate by the U.S. Department of Health and Human Services requiring private health insurance plans to cover all FDA-approved contraceptive drugs has generated a considerable amount of controversy. Much of the commentary and analysis has discussed whether this mandate violates the conscience rights of religious employers; however, there has been considerably less discussion as to whether these contraception mandates offer any significant public health benefit. Since the late 1990s,
approximately thirty states have required that privately bought health insurance plans cover contraception. A time series cross-sectional analysis of state level public health data offers important insights as to what impact these contraceptive mandates have on public health outcomes. Results
indicate that state contraception mandates have little impact on either unintended pregnancy rates or abortion rates.

Read Complete Article

Latest Posts

May 15, 2026 An orange prescription bottle labeled MISOPROSTOL, a common abortion pill, filled with yellow tablets sits in front of several white medicine bottles against a light blue background. Induced Abortion with Misoprostol Alone May 14, 2026 A person sits on an unmade bed facing a bright window with sheer curtains, their silhouette outlined by the warm, orange glow of sunlight—evoking a moment of quiet reflection on abortion in the dimly lit room. Reproductive Coercion and Abortion May 7, 2026 A developing human baby is shown on the right against a red background. On the left, a “New Updates” label, geometric logo, and a vertical measurement scale appear, highlighting Unborn Baby Development in a modern, medical-themed design. Charlotte Lozier Institute Launches Updated Unborn Baby Development Guide, New Pregnancy Calculator

You Might Also Be Interested In

An orange prescription bottle labeled MISOPROSTOL, a common abortion pill, filled with yellow tablets sits in front of several white medicine bottles against a light blue background.

Induced Abortion with Misoprostol Alone

May 15, 2026
Please login to bookmark Close
A person sits on an unmade bed facing a bright window with sheer curtains, their silhouette outlined by the warm, orange glow of sunlight—evoking a moment of quiet reflection on abortion in the dimly lit room.

Reproductive Coercion and Abortion

May 14, 2026
Please login to bookmark Close
An orange pill bottle, scattered white pills, and an ultrasound photo strip rest on a textured pink fabric surface, symbolizing the experience of a medical abortion.

Drug-induced Abortion After the First Trimester

April 14, 2026
Please login to bookmark Close

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image